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Abstract 
Human embryogenesis includes an integrated set of complex yet coordinated development of 
different organs and tissues, which is regulated by the spatiotemporal expression of many 
genes. Deciphering the gene regulation profile is essential for understanding the molecular 
basis of human embryo development. While molecular and genetic studies in mouse have 
served as a valuable tool to understand mammalian development, significant differences exists 
in human and mouse development at morphological and genomic levels. Thus it is important 
to carry out research directly on human embryonic development. Here we will review some 
recent studies on gene regulation during human embryogenesis with particular focus on the 
period of organogenesis, which had not been well studied previously. We will highlight a gene 
expression database of human embryos from the 4
th to the 9
th week. The analysis of gene 
regulation during this period reveals that genes functioning in a given developmental process 
tend to be coordinately regulated during human embryogenesis. This feature allows us to use 
this database to identify new genes important for a particular developmental process/pathway 
and deduce the potential function of a novel gene during organogenesis. Such a gene ex-
pression atlas should serve as an important resource for molecular study of human devel-
opment and pathogenesis. 
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Introduction 
Elucidating the molecular mechanisms govern-
ing human embryogenesis is a challenge even in the 
post-genomic era. Largely due to the obstacle in ob-
taining  suitable  human  embryos  for  biomedical  re-
search, for over 50 years, the mouse (Mus musculus) 
has  played  a  premier  role  as  a  model  for  studying 
early  human  development,  which  has  led  to  enor-
mous progress in our understanding of mammalian 
development. Elaborate genetic studies have revealed 
the function of many genes in development and ge-
nome-wide expression profile analyses have further 
identified many genes that are regulated during the 
earliest stages of mouse embryogenesis. On the other 
hand,  significant  developmental  differences  exist 
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between  human  and  model  organisms  including 
mouse at both  morphological and functional levels. 
More importantly, these differences appear to be ge-
netically determined, making it critical to carry out 
studies  directly  on  human  development.  Here,  we 
highlight some distinct features between human and 
mouse  development  and  review  some  recent  gene 
expression  studies  on  human  and  mouse  embryo-
genesis. We focus particularly on the recent studies on 
the  gene  regulation  during  organogenesis,  a  period 
that  had  not  been  previously  analyzed  at  ge-
nome-wide level even in mouse. 
Some distinct morphological and molecular 
features of mouse and human embryogen-
esis 
In the mammal, fertilization initiates a series of 
well-coordinated  developmental  events,  including 
morulation (preimplantation stage), gastrulation, and 
organogenesis  (postimplantation  stage).  Figure  1 
compares  the  developmental  stages  of  mouse  and 
human  embryos.  The  Theiler  Stages  (TS  1-28)  for 
mouse  embryos  are  based  in  part  on  the  somite 




Figure 1 Comparison of the developmental stages of mouse and human embryos. Mouse embryonic stages 
(Theiler stages or TS) are based on somite number and characteristics and consists of 28 stages from fertilized egg to birth, 
up to 20 days post conception (dpc) (the middle panel). The criteria for staging human embryos were described by the 
Carnegie Institution of Washington, which are based on the development of structures, not by size or the number of days 
of development. The corresponding stages of mouse and human are indicated by dashed lines. The lower panels indicate the 
TS or CS with the corresponding developmental time (dpc) for the mouse and human embryos, respectively. The 23 
Carnegie stages (CS) only covers the first 60 days of human embryo development, thereafter that the term embryo is 
replaced with fetus. The numbers in brackets above the large brackets for mouse and below the large brackets for human 
indicate the references that report previous human and mouse embryo transcriptome data of the indicated stages.  
 





The  Carnegie  Stages  (CS  1-23)  for  human  em-
bryos are based on the development of structures, not 
in the size or the number of days of development and 
it covers the first 60 days of development, at the end 
of which the term embryo is usually replaced with the 
term fetus [3]. Considering approximately 90 million 
years  of  independent  evolution,  it  is  not  surprising 
that  significant  morphological  differences  exist  in 
human  and  mouse  embryogenesis,  especially  some 
important  characteristics  developed  during  organo-
genesis. For example, the facial organs of human and 
mouse embryo develop in a very different sequence 
and form distinct features. While the optic pit is the 
earliest facial organ for mouse (a signature for all ro-
dent animal), essentially all human facial organs ap-
pear around the same time. The contralateral limbs of 
human  embryo  rotate  to  the  proper  positions  ven-
trally with flexible joints while the mouse limbs show 
little rotation and the joints are less flexible. Mouse 
embryo’s  tail  elongates  and  thins  from  TS17  while 
human embryo’s tail regresses during CS 23 (about 9th 
week  of  embryogenesis)  (Fig.  1).  Another  obvious 
difference between mouse and human embryogenesis 
is the time of birth. The mouse embryo is born almost 
immediately  after  all  the  organs  are  developed 
(around  TS27-TS28,  19-20  days  post  conception).  In 
contrast,  at  the  end  of  organogenesis  (CS23,  corre-
sponding to TS26, Fig. 1), the human embryo contin-
ues to stay in the uterus for a few more months: the 
fetal period of ongoing growth of many organs (Fig. 
1).  
While  the  anatomical  differences  between  hu-
man and mouse embryogenesis have been studied for 
over 100 years, systematic molecular analyses are be-
coming available in the last decade, thanks to the ad-
vances  in  genome  sequencing  and  microarray  tech-
nologies.  Human–mouse  genome-wide  comparisons 
have revealed a number of differences related to the 
species-specific  adaptations  especially  in  reproduc-
tion, immunity, and olfaction systems. These include 
many mouse genes missing in human and vice versa 
[4, 5] and distinct alternative splicing of orthologous 
genes associated with increased evolutionary change 
[6-8],  etc.  Interestingly,  the  most  significant  differ-
ences in mice and human are not in the number of 
genes that each has but in the expression of genes and 
the activities of their protein products [9]. Below, we 
will briefly summarize some of the microarray studies 
on  gene  expression  in  mouse  and  human  embryos 
[10-31].  
Gene expression studies of mouse and 
human embryos 
Genome-wide  expression  analyses,  especially 
microarray profiling, of human and mouse embryo-
genesis  have  provided  valuable  information  on  the 
deciphering  of  the  molecular  network  underlining 
morphological changes during development and in-
sights  into  mammalian  evolution.  During  the  past 
decades, most of the research on human and mouse 
embryos  focused  mainly  on  the  transcriptomes  of 
oocytes and preimplantation embryos [10-19, 24-29], 
largely due to the relative ease to obtain such embry-
os. Within this period, although there are little mor-
phological differences between the human and mouse 
embryo,  the  global  gene  expression  patterns  show 
dissimilarities. A characteristic difference is the timing 
of  transition  from  maternal  transcripts  to  zygotic 
transcripts. Human zygotic gene expression first oc-
curs between the four- and eight-cell stages of preim-
plantation  development  while  major  mouse  zygotic 
genome activation (ZGA) occurs at the two-cell stage 
[32,  33].  Furthermore,  human  preimplantation  de-
velopment consists of two main phases: one from the 
meiosis  II  (MII)  oocyte  to  4-cell  embryo  when  the 
maternal genes predominate, and the other from the 
8-cell embryo to the blastocyst when maternal genes 
are downregulated while zygotic genes are upregu-
lated [29]. While in mouse, there are two major tran-
scriptional waves during preimplantation. One group 
of zygotic genes are activated at the 2-cell stages and 
appear  to  be  preferentially  those  involved  in  tran-
scription and RNA processing [15]. The other group 
of genes are activated in 4-cell to 8-cell embryos and 
are involved mostly in morphological and functional 
changes of the embryos [13]. 
Despite these differences, there are also a num-
ber  of  common  signaling  processes  during  early 
mouse  and  human  development,  suggesting  that 
during preimplantation, many molecular mechanisms 
are  evolutionarily  conserved  between  human  and 
mouse [16, 28]. These include the Notch, TGFβ/BMP, 
and Wnt pathways etc. The same ligands and recep-
tors of these signaling pathways are temporally and 
spatially  regulated  to  determine  zygote  asymmetry, 
cell fate, cell polarity, communication, adhesion and 
migration,  and  they  are  important  for  both  hESCs 
(human  embryonic  stem  cells)  and  mESCs  (mouse 
embryonic stem cells) [34, 35]. For example, expres-
sion of type I and type II receptors for TGF-β both in 
mouse and human fertilized oocytes and blastocysts 
suggests  a  role  for  TGF-β  in  early  preimplantation 
development [36]. 
After  implantation,  especially  during  organo-
genesis,  notable  morphological  differences  exist  be-
tween  mouse  and  human  development,  suggesting 
the  existence  of  different  gene  expression  profiles. 




sion  patterns  were  reported  between  human  and 
mouse  development  for  a  variety  of  genes  such  as 
Wnt7a and CAPN3, particularly in the formation of 
neural crest, midbrain, lens, heart, and smooth muscle 
[37,  38].  Unfortunately,  few  genome-wide  gene  ex-
pression  analyses  have  been  carried  out  on  either 
mouse or human post-implantation embryos.  
Recently, Fang et al. and Yi et al. independently 
reported the global gene  expression patterns of hu-
man embryos covering the whole organogenesis pe-
riod (CS9-CS23) [30, 31]. In the study by Fang et al. 
human  embryos  were  grouped  into  six  embryonic 
developmental  stages  (CS9-CS14)  and  microarray 
analysis was carried out for every stage. On the other 
hand, Yi et al. isolated total RNA from human em-
bryos  for  each  week  of  4th–9th  weeks  (CS10-23)  for 
expression profiling. Both studies employed the Hu-
man Genome U133 Array by Affymetrix (Santa Clara, 
CA, USA). Although different methods were used for 
data analysis, both groups found that the regulated 
genes during the organogenesis period could be di-
vided into two  major groups. Fang et al. defined  a 
gradual decrease in ‘stemness’ concomitant, cell cycle, 
and metabolism-related genes, and an increase in or-
ganogenesis specific genes, including muscle, fat, and 
connective  tissue  specific  genes  and  differentia-
tion-associated gene, etc.  Similarly,  Yi et al.  discov-
ered  an  up-regulation  of  gene  categories  enriched 
with genes involved in multi-cellular organismal de-
velopment/processes,  cell  adhesion,  cell  surface  re-
ceptor-linked signaling, and cell–cell signaling, which 
correlate  well  with  the  differentiation  and  develop-
ment  of  organs  that  takes  place  during  the  4th–9th 
weeks,  and  observed  the  down-regulation  of  gene 
categories associated with various metabolic process-
es  and  transcriptional  regulation  that  are  likely  in-
volved in the transition of the embryo from mainly 
cell proliferation in the 4th week to mostly organ de-
velopment by the 8th–9th weeks. In addition, Yi et al. 
identified many genes with an arch-shaped gene ex-
pression pattern during the 4th-9th week of develop-
ment,  which  were  enriched  with  a  number  of  GO 
categories, such as those related to eye development 
with the peak level expression of the genes correlated 
well with the formation of the lens and the develop-
ment of retinal pigmentation during the 5th–7th weeks 
of embryogenesis. These studies by Fang et al. and Yi 
et al. using embryos covering overlapping develop-
mental periods (CS9-14 and CS10-23, respectively) not 
only confirm the findings but also complement each 
other to offer a more complete molecular profile of 
early human embryogenesis.  
These studies also enable us to do comparative 
study  to  reveal  distinct  features  in  human  embryo 
development. For instance, given the differences and 
similarities between mouse and human embryogene-
sis, an important question is to what extent the gene 
expression profiles are conserved between mouse and 
human  embryos.  The  period  of  human  embryonic 
developmental  stages  CS9-CS14  [30]  resembles  that 
from  gastrulation  to  early  organogenesis  of  mouse 
embryos  (from  TS12-TS17)  [21].  Consistently,  our 
analysis  showed  that  dramatic  changes  in  gene  ex-
pression profiles occurred at the beginning of organ-
ogenesis in both mouse (around TS 12, embryonic day 
8) and human (around CS9-CS10, or embryonic week 
3/4) [21, 30]. Fang et al. further found out that the 
human-mouse  homologs  in  the  down-regulated 
group are primarily linked to embryonic lethality and 
abnormal lipid circulation. They believed that these 
genes should be important for the initiation of mam-
malian embryo organogenesis. In addition, genes re-
lated to myogenesis, osteogenesis, heart development, 
and  neurogenesis  were  also  found  to  be  similarly 
regulated in human and mouse during organogenesis, 
displaying a gradually increase in expression. Inter-
estingly, transcriptome comparison has also identified 
a set of genes that are expressed early in human em-
bryonic  development  but  have  not  yet  been  impli-
cated in early mouse development [30]. For example, 
PAX6 appears to be a human neuroectoderm cell fate 
determinant and regulate forebrain development but 
it is not required in mouse [39]. Such differences argue 
that obtaining the panorama of regulation gene pro-
file in human embryo is indispensible for us to fully 
understand human development. 
The  embryonic  processes  that  occur  between 
fertilization  and  gastrulation  (0–4th  week)  are  ana-
tomically distinct from the subsequent organogenesis 
and histogenesis (4th–9th week). However, the under-
lying molecular basis of this change remains elusive. 
By comparing their gene regulation data with those 
on human oocytes and very early embryos (up to day 
3) [26, 27], Yi et al. found that the developmentally 
regulated genes during the 4-9th week fell into several 
functional  categories/pathways,  which  are  distinct 
from  those  associated  with  the  maternal  genes  that 
function in early embryonic processes between ferti-
lization  and  gastrulation.  The  traditionally  highly 
expressed maternal transcripts could be divided into 
three groups, absent by the 4th week (about 26.7%), 
regulated during the 4-9th week (about 14.9%, mostly 
are  down-regulated),  and  constitutively  expressed 
during  the  4-9th  week  (the  rest)  [31].  The  first  two 
groups  of  maternal  genes  are  significantly  enriched 
with genes involved in membrane utilization, metab-
olism, and cell cycle regulation, all of which are im-




down-regulated  subsequently.  Genes  in  the  third 
group are more likely housekeeping genes, as they are 
constitutively  expressed  at  least  until  9th  week  of 
embryogenesis. These genes seem not to be specific 
for any developmental processes, at least up to the 9th 
week. These results indicate that the very early phase 
of embryogenesis utilizes maternal genes in the GO 
categories related to membrane, metabolism, and cell 
cycle  while  the  subsequent  organ  development  uti-
lizes mainly zygotically transcribed genes belonging 
to distinct GO categories. Similarly, Fang et al. com-
pared their data with the hESC genes and differentia-
tion genes defined by Assou et al. [40] and found that 
the genes with reduced expression during CS9-CS14 
significantly  overlapped  with  the  stemness-specific 
genes, in agreement with Yi et al.’s observation that 
most  maternal  genes  are  not  detected  or 
down-regulated by the 4th week of human embryo-
genesis (CS10). Some notable examples of these genes 
include the core stem cell identity controlling genes 
OCT4, NANOG, and SOX2 [30, 31, 41]. While the po-
tential binding sites of these genes were found to be 
significantly enriched in hESC D group (the overlap-
ping genes between decreasing clusters of CS9-CS14 
and hESC genes), suggesting that the expression of 
these genes were no longer needed in the organogen-
esis  period.  This  is  in  accordance  with  that  the  ex-
pression  of  OCT4,  NANOG,  and  SOX2  were  both 
down-regulated seriously or even undetected during 
the 4-9th week of embryogenesis. 
Aside from the common findings, Yi et al. have 
also identified some  unique features in  human em-
bryo  development.  For  instance,  they  revealed  that 
approximate half of all human genes were expressed 
and 18.6% of the expressed genes were differentially 
regulated  during  the  human  organogenesis  period 
(CS10-23).  Surprisingly,  only  1,099  of  the  regulated 
transcripts (26.1% of the 4,203 genes) had previously 
been implicated to be related to development. Thus, 
most  of  the  genes  regulated  during  this  important 
period  of  human  development  represent  novel  de-
velopment-related genes. More importantly, by ana-
lyzing  how  genes  involved  in  a  given  biologi-
cal/developmental process or GO category are regu-
lated during the 4
th-9
th week of human embryogenesis, 
they  have  observed  strong  co-regulation  of  these 
genes and that their regulation correlates  well with 
the developmental changes associated with  this pe-
riod [31]. For example, the vast majority of the genes 
associated with stem cells are highly expressed during 
the 4th or 5th weeks but are down-regulated by the 9th 
week, consistent with their roles in stem cells since the 
number of stem cells or undifferentiated cells is re-
duced when more cells begin to differentiate into dif-
ferent  organ/tissue-specific  cell  types  toward  the 
8th-9th week of development. Likewise, the vast ma-
jority of the genes likely involved in organ develop-
ment, such as genes associated with muscle, fat, and 
connective  tissues  or  those  associated  with  internal 
organs or blood and lymph tissues are coordinately 
upregulated,  with  the  highest  levels  of  expression 
occurring in the 9th week, in agreement with the on-
going  organogenesis.  Such  findings  suggest  that 
genes participating in the same  developmental pro-
cesses tend to be regulated coordinately during the 
4th-9th week of development. 
A novel in-silico resource for identifying 
genes involved in and predicting gene 
function during a developmental process 
The co-regulation of genes in a given GO cate-
gory during the 4th -9th week of human embryogenesis 
has led us to propose that our gene expression data-
base [31] can be used as a searchable resource. That is, 
one can use it to search for genes likely involved in a 
particular developmental process or inferring the bi-
ological functions of a gene of interest, if it is among 
the regulated genes, during this developmental peri-
od.  This  is  important  because  the  developmental 
functions of many genes are unknown and that many 
genes  involved  in  different  developmental  process 
also remain to be identified.  
The gene expression atlas is a simple searchable 
database  (http://vmolab.whu.edu.cn:8080/Human 
GeneSearch/). Fig. 2 outlines the basic steps to use the 
database. 
A. To predict the potential developmental role 
of an unknown gene X (Fig. 2, left panel) 
1. Search the database to obtain the expression 
profile of Gene X 
2. Cluster the expression  profile of Gene  X to-
gether with all developmentally regulated genes (the 
list can be downloaded from the database) by hierar-
chical clustering methods 
3.  Identify  the  gene  cluster  most  closely 
co-regulated with Gene X  
4. Analyze the gene cluster with Gene Ontology 
or GenMaPP to determine potential roles of or poten-
tial pathways involving Gene X (user can adjust the 
coefficient to define the size of the gene cluster in step 
2, in order to get satisfied GO function categories)  
5. Experimental validation (e.g., confirmation of 
the expression profile by RT-PCR, in situ hybridiza-
tion,  and/or  immunohistochemistry,  functional 
analysis  in  cultured  cells  or  in  vivo  by  using  gene 
knock-out or transgenesis, etc.) 






Figure 2 Schematic diagram for using the expression database to predict the potential roles of unknown 
genes and identify genes involved in a particular biological process during the 4
th-9




B. To identify genes involved in a particular 
biological process or cellular pathways (Fig. 2, 
right panel) 
1. Search the database to obtain the expression 
profiles of all genes known to be involved in a given 
biological/developmental process Y (e.g., a particular 
GO category) 
2.  Identify  the  expression  signature  of  these 
genes (may get more than one featured cluster) 
3. Cluster the expression patterns of these genes 
with  all  unknown  but  developmentally  regulated 
genes  
4.  Identify  the  unknown  genes  that  are 
co-regulated with the genes involved in the biologi-
cal/developmental process Y. (again, user can adjust 
the coefficient to define the size of the signature gene 
cluster in step 2, or use different signature cluster in 
order to get enough unknown genes) 
5. Experimental validation (e.g., confirmation of 
the expression profile by RT-PCR, in situ hybridiza-
tion,  and/or  immunohistochemistry,  functional 
analysis  in  cultured  cells  or  in  vivo  by  using  gene 
knock-out or transgenesis, etc.) 
As a test and an example for using this atlas with 
pipeline A, a novel developmentally regulated genes, 
C2orf40 (chromosome 2 open reading frame 40), was 
analyzed as described above [31]. Firstly searching the 
microarray  database  revealed  that  it  is  upregulated 




an obvious increasing trend in the 7th week. Then we 
clustered its expression profile with all  5,358 devel-
opmentally regulated genes during the 4th-9th week of 
human  embryogenesis,  showing  that  its  temporal 
regulation pattern is similar to a small cluster of 59 
genes (Fig. 3B, right panel, indicted by the purple-red 
bar). These genes are highly enriched with GO cate-
gories  involved  in  skeletal  development,  collagen, 
cartilage  development,  and  the  extracellular  matrix, 
suggesting that C2orf40 is likely involved in skeletal 
development. Indeed, in situ hybridization revealed 
that C2orf40 has little expression in the 4th week but is 
upregulated in the skeletal system by the 7th-9th week. 
In particular, it is highly expressed in the vertebrae by 
the 7th week. These spatial patterns provide further 
support  that  the  C2orf40  gene  is  likely  involved  in 
skeletal and cartilage development, although further 
experimentation is required to demonstrate its func-
tion. Actually, we can also use pipeline B to confirm 
the  inferring  of  pipeline  A.  We  combined  the 
well-known 148 skeletal  genes to combine with the 
1,218  developmentally  regulated  genes  with  no 
known  GO categories and clustered them based on 
their expression profiles. We identified four signature 
non-overlapping clusters with some unknown genes 
(see the Figure 5 of Reference 31), while C2orf40 was 
exactly  in  one  of  them.  These  and  other  analyses 
suggest that the gene expression atlas can be a valua-
ble  resource  for  understanding  the  molecular  path-





Figure 3 Gene expression profiles suggest a potential role in skeletal development for a novel develop-
mentally regulated gene C2orf40. A, The C2orf40 expression profile as obtained from the expression database. B, The 
expression profile of C2orf40 clustered with all developmentally regulated genes. A cluster of genes that most closely 
co-regulated with C2orf40 was identified by their correlation efficient and indicated with a purple bar on the right, and was 
expanded (right panel, with the location of C2orf40 indicated). Some significant GO categories associated with these 
clusters are shown on the right; they are all associated with skeletal development. 
 
Conclusions and perspectives 
The advances in genetics and genome sequence 
information in the past two decades has made mouse 
an  extremely  valuable  model  for  understanding 
mammalian  development.  However,  the  divergence 
in  morphological  and  molecular  changes  during 
mouse  and  human  embryogenesis  argues  that  it  is 
important to carry out, to the extent possible, research 
directly on human embryos. On the other hand, be-
cause of obvious ethical concerns, human embryonic 
tissues  are  hard  to  obtain.  Thus,  the  knowledge  on 
human embryonic development has been mostly on 
oocytes, hESCs, and very early human embryos. The 
two  recent  microarray  analyses  on  human  embryo-
genesis have provided the first glimpse on the global 
gene expression profiles during human organogenesis 




ing  the  molecular  pathways  of  human  embryonic 
development. More importantly, the database for the 
gene expression profiles of the 4th to 9th weeks of hu-
man development appears to function as a valuable 
resource for identifying novel genes involved in and 
predicting  the  potential  roles  of  developmentally 
regulated genes during organogenesis, a critical pe-
riod with little prior molecular knowledge. A pressing 
task is to further improve and expand our database as 
more information on human development is collected 
with  the  development  of  new  technologies  such  as 
next-generation  seq,  RNA-seq,  etc.  This  should  en-
hance the value of the database for studying the mo-
lecular  basis  of  human  development.  Finally,  it  is 
worth mentioning that the most significant morpho-
logical  differences  between  mouse  and  human  de-
velopment appear during organogenesis. The human 
gene expression atlas should also aid in the determi-
nation of the molecular basis underlying the conser-
vations and evolutionary divergences between mouse 
and  human  development  once  the  transcriptome 
analyses of corresponding period of mouse embryos 
are carried out. Given the advances in mouse genetics, 
such information will be extremely useful for future 
functional  dissections  of  the  molecular  mechanisms 
underlying mammalian organogenesis.  
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